Expert Opinion on Therapeutic Targets

Papers
(The H4-Index of Expert Opinion on Therapeutic Targets is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Decoding the expression pattern of MUC3A in gastric adenocarcinoma: unveiling the key to successful immunotherapy114
Calcium channelopathies in neurodegenerative disorder: an untold story of RyR and SERCA57
IL-36: a therapeutic target for ulcerative colitis?52
The clinical and immunological features of alopecia areata following SARS-CoV-2 infection or COVID-19 vaccines48
Interleukin-18 in cancer immunology and immunotherapy43
Mitochondrial permeability transition pore: a snapshot of a therapeutic target38
Targeting transcription in neuroblastoma: focus on the core regulatory circuit38
Potential role of indole-3-propionic acid in tuberculosis: current perspectives and future prospects36
The sigma–1 receptor: a mechanistically–informed therapeutic target for antidepressants33
Glycoproteins and longevity: an interview with Professor Gordan Lauc32
Molecular basis for targeting TBK1 in CAR-T cell therapies for cancer32
Emerging therapeutic targets for idiopathic pulmonary fibrosis: preclinical progress and therapeutic implications31
Novel regulators of airway epithelial barrier function during inflammation: potential targets for drug repurposing30
Pleural mesothelioma: a snapshot of emerging drug targets and opportunities for non-surgical therapeutic advancement30
NRG1 and NRG2 fusions in non-small cell lung cancer (NSCLC): seven years between lights and shadows28
Kallikrein-related peptidases: mechanistic understanding for potential therapeutic targeting in cancer28
MDA-9/Syntenin as a therapeutic cancer metastasis target: current molecular and preclinical understanding26
Current challenges in the discovery of treatments against Mayaro fever26
A short report on NGM282/aldafermin for the treatment of nonalcoholic steatohepatitis (NASH)26
The potential of multimolecular G-quadruplex structures for targeted treatment of Amyotrophic Lateral Sclerosis25
PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study25
Lipid-laden foam cells in the pathology of atherosclerosis: shedding light on new therapeutic targets24
Therapeutic targeting of the polyglutamine androgen receptor in Spinal and Bulbar Muscular Atrophy24
Clostridioides difficile: innovations in target discovery and potential for therapeutic success24
0.10395693778992